Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ILOPROST
- Oral Iloprost for the Prevention of Lung Cancer In Former Smokers
- Rheopheresis for Raynaud's and Digital Ulcers in Systemic Sclerosis
- Effects of Iloprost on Oxygenation During One-lung Ventilation in Supine-positioned Patients
- Treatment of Pulmonary Hypertension in High-risk Cardiac Surgery Patients Using Inhalational and Intravenous Agents
- Pirfenidone Compared to Placebo in Post-COVID19 Pulmonary Fibrosis COVID-19
- Levosimendan Administration in Pulmonary Hypertension
- Effect of Intraoperative Iloprost Inhalant on Hemodynamic Stability in Patients Undergoing Off-pump Coronary Artery Bypass Graft Surgery
- Effects of Iloprost on Pulmonary Oxygenation in Obese Patients During One-lung Ventilation
- A Clinical Trial Investigating Iloprost as Medication to Improve Bone Healing in Patients With Proximal Humeral Fracture
- Inhaled Iloprost for Suspected COVID-19 Respiratory Failure
- Infusion of Prostacyclin (Iloprost) vs Placebo for 72-hours in COVID-19 Patients With Respiratory Failure
- Infusion of Prostacyclin (Iloprost) vs Placebo for 72-hours in Patients With Septic Shock Suffering From Organ Failure
- Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 3)
- The Effect of Iloprost on Oxygenation During One-lung Ventilation for Lung Surgery
- Infusion of Prostacyclin vs Placebo for 72-hours in Trauma Patients With Haemorrhagic Shock Suffering From Organ Failure
- Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 2)
- Efficacy of Botulinum Toxin A in Adult Subjects With Raynaud Phenomenon Secondary to Systemic Sclerosis
- Inhaled Iloprost and Exercise Hemodynamics and Ventricular Performance in Heart Failure With Preserved Ejection Fraction
- The Effect of Iloprost on Capillary Recruitment and Insulin Sensitivity in Type 2 Diabetes
- Acute Response of Iloprost Inhalation Using the Breelib Nebulizer in Pulmonary Arterial Hypertension
- Treprostinil Iontophoresis in Systemic Sclerosis Digital UlcErations. A Proof of Concept Study
- Iloprost in Acute Respiratory Distress Syndrome
- Outpatient Vasodilator Assessment Using Iloprost in Pulmonary Hypertension
- Examination of Ventavis (Iloprost) Inhalation Behavior Using the I-Neb AAD System in Patients With Pulmonary Arterial Hypertension When Switching the Iloprost Nebulizer Solution for Inhalation From 10 μg/mL (V10) to 20 μg/mL (V20)
- Effect of Iloprost on Pulmonary Oxygenation in Patients With Low Diffusing Capacity During One-lung Ventilation
- Endothelial Dysfunction in Resuscitated Cardiac Arrest
- Effects of Iloprost on Pulmonary Hemodynamics and Oxygenation in Patients of Chronic Obstructive Pulmonary Disease During One-lung Ventilation
- Iloprost for Bridging to Heart Transplantation in PH
- Iloprost in Preventing Lung Cancer in Former Smokers
- Co-administration of Iloprost and Eptifibatide in Septic Shock Patients
- Pulmonary Rehab in Chronic Obstructive Pulmonary Disease (COPD): Response to Tyvaso
- Inhaled Aerosolized Prostacyclin for Pulmonary Hypertension Requiring Inhaled Nitric Oxide
- Comparative PK PD Study in PAH Patients (Fox vs. I-Neb)
- Inhaled Iloprost, Dynamic Hyperinflation, and Oxidative Stress in COPD Patients
- Non-interventional Multi-center Study on Patients Under Routine Treatment of Pulmonary Arterial Hypertension (PAH) With Inhaled Iloprost Using I-Neb as a Device for Inhalation
- Observational Description of Compliance for the Daily Ventavis Use Via the Insight Program in Class III Pulmonary Arterial Hypertension Patients
- The Arterial Measurement of the Blood Flow Volume After Iloprost Stimulation
- A Study of Ranolazine Acute Administration and Short Term Administration in Pulmonary Arterial Hypertension
- Optimization of Treatment in Patients With Severe Peripheral Ischemia (Fontaine Stage IIb)
- Study of the Initial Combination of Bosentan With Iloprost in the Treatment of Pulmonary Hypertension Patients
- Vardenafil as add-on Therapy for Patients With Pulmonary Hypertension Treated With Inhaled Iloprost
- Multicenter Study of Iloprost Inhaled in Pulmonary Hypertension After Repair of Congenital Heart Diseases (CHD)
- Treprostinil Iontophoresis : a Pharmacodynamic and Pharmacokinetic Study
- Enhanced Assisted Reproductive Technology Pregnancy Rate by Prostacyclin Analog (Iloprost)
- Integrilin and Ilomedin in Combination in Comparison to Standard Treatment in Severe Pneumonia Patients With Severe Sepsis
- Inhaled Iloprost (Ventavis): Efficacy, Safety, and Pharmacokinetics (PK) Confirmation Study
- Iloprost Therapy in Patients With Critical Limb Ischemia
- Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)
- Inhaled Iloprost in the Treatment of Patients With Pulmonary Hypertension up to 4 Years
- Efficacy of Ventavis Used in Real-life Setting.
- Study of Inhaled Iloprost for the Treatment of Pulmonary Hypertension After Repair of Congenital Heart Disease
- Iloprost for the Treatment of Pulmonary Hypertension in Adults With Congenital Heart Disease
- Study of Inhaled Iloprost in Pediatric Pulmonary Hypertension (PH) After Surgery
- Iloprost Effects on Gas Exchange and Pulmonary Mechanics
- Inhaled Iloprost in Mild Asthma
- Ilomedin Treatment for Patients Having Undergone Primary Percutaneous Coronary Intervention (PCI)
- Inhaled Iloprost for Disproportionate Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease (COPD)
- Cutaneous Iontophoresis of Iloprost and Treprostinil in Healthy Volunteers
- Effect of BMPR-2 Gene Mutations on Hemodynamic Response by Iloprost Inhalation in Pulmonary Arterial Hypertension
- Inhaled Iloprost as an Adjunct to Inhaled Nitric Oxide in Pediatric Critical Care Patients
- Iloprost in High Risk Cardiac Surgical Patients
- Ventavis® Registry Protocol
- Post-Marketing Surveillance of Ventavis® in Chinese Patients With Primary Pulmonary Hypertension (PPH)
- Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in Pulmonary Arterial Hypertension (PAH) Subjects
- Effects of Iloprost on Hypoxic Pulmonary Vasoconstriction at Altitude
- Iloprost Power Disc-15 in Pulmonary Arterial Hypertension
- The Efficacy and Safety of Vardenafil in the Treatment of Pulmonary Arterial Hypertension
- Iloprost Power 15 in Pulmonary Arterial Hypertension
- Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
- Effects of Iloprost on Hypoxic Pulmonary Vasoconstriction and Exercise Capacity at High Altitude
- Long Acting Phosphodiesterase 5 Inhibitors as Add-on Therapy for Patients With Pulmonary Hypertension Treated With Prostanoids.
- Sildenafil for Treatment of Digital Ulcers in Patients With Systemic Sclerosis
- Effect of Different Iloprost Doses on Symptoms in Systemic Sclerosis
- Therapy of Pulmonary Arterial Hypertension (PAH) - Treatment With Sildenafil in Eisenmenger Patients
- Iloprost in Gas Exchange/Pulm Mechanics in Chronic Obstructive Pulmonary Disease (COPD)
- The "Power 15 Study": Safety Study of Inhalation of Ventavis With the Power Disc-15 Setting
- Transitioning To IV Remodulin From Ventavis in Patients With PAH: Safety, Efficacy and Treatment Satisfaction
- Safety and Efficacy of Inhaled Iloprost in Pediatric Patients With Pulmonary Arterial Hypertension
- Sorafenib Study: Dosing in Patients With Pulmonary Arterial Hypertension (PAH)
- Trial of Iloprost in Pulmonary Hypertension Secondary to Pulmonary Fibrosis
- High Dose Intravenous N-Acetylcysteine Versus Iloprost for Early, Rapidly Progressive Diffuse Systemic Sclerosis
- Aerosolized Randomized Iloprost Study II (AIR - II) Long-Term Safety, Tolerability, and Clinical Effects of Iloprost Inhalation in Patients With Primary or Secondary Pulmonary Hypertension
- Inhaled Iloprost for the Treatment of Persistent Pulmonary Hypertension in the Term and Near Term Infants.
- Inhaled Iloprost for Sarcoidosis-associated Pulmonary Hypertension
- Iloprost for Prevention of Contrast-Mediated Nephropathy in High-Risk Patients Undergoing Coronary Angiography and/or Intervention
- Inhaled Prostacyclin for Adult Respiratory Distress Syndrome (ARDS) and Pulmonary Hypertension
- The "VISION" Trial: Ventavis Inhalation With Sildenafil to Improve and Optimize Pulmonary Arterial Hypertension
- Bosentan in Treatment of Pulmonary Arterial Hypertension
- Observation of Patients With Primary Pulmonary Hypertension Receiving Prescribed Ventavis Inhalation Therapy Regarding Safety and Efficacy for up to 4 Years
- Iloprost-Study: Comparison of Nitric Oxide to Iloprost (Ventavis) for Treatment of Pulmonary Hypertension in Children After Cardiopulmonary Bypass Surgery
- Treatment of Elevated Arterial Pulmonary Pressure With Inhaled Iloprost
- Safety Follow-up Study of Inhaled Iloprost in Patients With Pulmonary Hypertension
- Efficacy of Type-5 Phosphodiesterase Inhibitors in Primary and Secondary Pulmonary Hypertension
- Combination Therapy of Bosentan and Aerosolized Iloprost in Idiopathic Pulmonary Arterial Hypertension (IPAH)
- Inhaled Iloprost in Adults With Abnormal Pulmonary Pressure and Associated With Idiopathic Pulmonary Fibrosis
- Trial of Iloprost Inhaled Solution as Add-On Therapy With Bosentan in Subjects With Pulmonary Arterial Hypertension (PAH)
- Iloprost in Preventing Lung Cancer in Patients at High Risk for This Disease
- Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Iloprost for Raynaud's Phenomenon Secondary to Systemic Sclerosis
Clinical trials list
click for details